Distinguished in Erosive Pustular Dermatosis of the Scalp

Annalisa Patrizi

St. Orsola Malpighi University Hospital, 
Bologna, IT 
Distinguished in Erosive Pustular Dermatosis of the Scalp
St. Orsola Malpighi University Hospital, 
Bologna, IT 
OverviewLocationsClinical Research

Overview

Annalisa Patrizi practices in Bologna, Italy. Ms. Patrizi is rated as a Distinguished expert by MediFind in the treatment of Erosive Pustular Dermatosis of the Scalp. Her top areas of expertise are Pyogenic Granuloma, Erosive Pustular Dermatosis of the Scalp, Atopic Dermatitis, and Perniosis.

Her clinical research consists of co-authoring 563 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Erosive Pustular Dermatosis of the Scalp.

Gender
Female

Locations

St. Orsola Malpighi University Hospital, Bologna, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

562 Total Publications

Focal facial dermal dysplasia type IV: a case series.
Focal facial dermal dysplasia type IV: a case series.
Journal: Dermatology reports
Published: November 24, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Patrizi's expertise for a condition
ConditionClose
    View All 16 Distinguished Conditions
    View All 49 Advanced Conditions
    View All 118 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile